跳至主要内容
临床试验/EUCTR2011-000396-14-GB
EUCTR2011-000396-14-GB进行中(未招募)1 期

The use of Ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome? - The use of Ketamine as an anaesthetic during electroconvulsive therapy

niversity of Aberdeen0 个研究点目标入组 40 人开始时间: 2011年4月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - Between the ages of 18 and 75. - Diagnosed with depression and being referred for ECT. - American Society of Anesthesiologists (ASA) score of 1 or 2. - Patient receiving ECT on an informal basis (i.e. consenting to treatment and able to give informed consent).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - pre-existing neurological disease or cognitive impairment - co-morbid psychiatric diagnoses - pre-existing severe hypertension - severe respiratory tract disease - major cardiovascular disease - pacemakers - significant cerebrovascular disorder or malformation - intracranial mass lesions - seizure disorder - intracranial electrode and clips - severe intra-ocular pathology - significant endocrine or metabolic disease - severe hematologic disease - severe fracture - not able to give consent - pregnancy - obesity

研究者

发起方
niversity of Aberdeen

相似试验

The use of Ketamine as an anaesthetic during... | 临床试验